1. Home
  2. OSIS vs CNTA Comparison

OSIS vs CNTA Comparison

Compare OSIS & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • CNTA
  • Stock Information
  • Founded
  • OSIS 1987
  • CNTA 2020
  • Country
  • OSIS United States
  • CNTA United Kingdom
  • Employees
  • OSIS N/A
  • CNTA N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSIS Technology
  • CNTA Health Care
  • Exchange
  • OSIS Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • OSIS 3.3B
  • CNTA 2.3B
  • IPO Year
  • OSIS 1997
  • CNTA 2021
  • Fundamental
  • Price
  • OSIS $208.15
  • CNTA $17.37
  • Analyst Decision
  • OSIS Strong Buy
  • CNTA Strong Buy
  • Analyst Count
  • OSIS 5
  • CNTA 8
  • Target Price
  • OSIS $201.20
  • CNTA $23.00
  • AVG Volume (30 Days)
  • OSIS 242.6K
  • CNTA 711.3K
  • Earning Date
  • OSIS 01-23-2025
  • CNTA 03-27-2025
  • Dividend Yield
  • OSIS N/A
  • CNTA N/A
  • EPS Growth
  • OSIS 18.05
  • CNTA N/A
  • EPS
  • OSIS 7.78
  • CNTA N/A
  • Revenue
  • OSIS $1,650,140,000.00
  • CNTA $6,853,000.00
  • Revenue This Year
  • OSIS $12.49
  • CNTA N/A
  • Revenue Next Year
  • OSIS $5.20
  • CNTA N/A
  • P/E Ratio
  • OSIS $26.79
  • CNTA N/A
  • Revenue Growth
  • OSIS 20.69
  • CNTA N/A
  • 52 Week Low
  • OSIS $126.57
  • CNTA $7.75
  • 52 Week High
  • OSIS $212.00
  • CNTA $19.09
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 73.10
  • CNTA 56.50
  • Support Level
  • OSIS $200.57
  • CNTA $15.56
  • Resistance Level
  • OSIS $201.42
  • CNTA $19.09
  • Average True Range (ATR)
  • OSIS 7.21
  • CNTA 1.15
  • MACD
  • OSIS 1.51
  • CNTA 0.23
  • Stochastic Oscillator
  • OSIS 87.83
  • CNTA 63.69

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. Majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East, and Africa, and the Asia Pacific regions.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Share on Social Networks: